Skip to product information
1 of 1

GeneBio Systems

SLC3A2 Polyclonal Antibody

SLC3A2 Polyclonal Antibody

SKU:E-AB-18594

Regular price ¥91,000 JPY
Regular price Sale price ¥91,000 JPY
Sale Sold out
Shipping calculated at checkout.

Size: 200μL

Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.

Exp date: 12 months

Category ID_II: Primary Antibodies

Category ID_III: Polyclonal Antibodies

Abbreviation: SLC3A2

Target Synonym: 4F2;4F2 cell surface antigen heavy chain;4F2 cell-surface antigen heavy chain;4F2 heavy chain;4F2 heavy chain antigen;4F2;4F2hc;4T2HC;Antigen defined by monoclonal 4F2 heavy chain;Antigen identified by monoclonal antibodies 4F2 TRA1.10 TROP4 and T43;CD 98;CD98;CD98 antigen;CD98 heavy chain;CD98HC;Heavy chain;Lymphocyte activation antigen 4F2 large subunit;MDU 1;MDU1;Monoclonal 44D7;NACAE;Slc3a2;Solute carrier family 3 (activators of dibasic and neutral amino acid transport) member 2;Solute carrier family 3 member 2

Research Areas: Cancer;Metabolism;Immunology;Signal Transduction;Stem Cells

Conjugation: Unconjugated

Host: Rabbit

Species reactivity: Human

Application: WB

Isotype: IgG

Clonality: Polyclonal

Clone NO.:

UNIProt ID: P08195

Accession:

Background: This gene is a member of the solute carrier family and encodes a cell surface, transmembrane protein. The protein exists as the heavy chain of a heterodimer, covalently bound through di-sulfide bonds to one of several possible light chains. The encoded transporter plays a role in regulation of intracellular calcium levels and transports L-type amino acids. Alternatively spliced transcript variants, encoding different isoforms, have been characterized.

Concentration: 0.6 mg/mL

Immunogen: Fusion protein of human SLC3A2

Buffer: PBS with 0.05% NaN3 and 40% Glycerol,pH7.4

Purification method: Antigen affinity purification

Dilution: WB 1:500-1:2000

Calculated MW: 68 kDa

ObservedMW: Refer to figures

View full details